CytoCore, the developer of cost-effective products used in the practice of cytology for the detection and diagnosis of cancer and cancer related diseases, has reported that the study led by UCLA School of Nursing associate professor, Dr Dorothy Wiley, has been funded by an initial grant from the UCLA School of Nursing and intended to identify low cost diagnostic solutions for cervical cancer screening in resource poor area.

Robert McCullough, CEO of CytoCore, said: “We obtained commercial licenses from QuantRx for PadKit for all cytology applications involving the collection of cellular samples that can be screened for a variety of gynecological cancers including cervical, endometrial, and ovarian, and for the collection of gynecological samples to be tested for the presence of human papillomavirus (HPV).

“We believe PadKit will be an effective complement to SoftPap within our CytoCore Solutions family of products for the collection, preparation and analysis of cytology specimens for the detection of precancerous and cancerous conditions.”

William Fleming, president and chief scientific officer of QuantRx, said: “we continue to work closely with CytoCore and their talented group of engineers and scientists and are pleased with the progress we have jointly achieved since the inception of our relationship 18 months ago. We are excited about the prospect of PadKit and its application to CytoCore Solutions involving cytology applications.”